ProQuest Associates IV LLC, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 130,228 shares at $85.16 ($11.1M) on 2017-01-04, disclosed to the SEC on 2017-01-06.
Open-market sale of $11.1M EGRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.16 | 65,114 | $5.5M | 50.0% |
| 2 | $85.16 | 65,114 | $5.5M | 50.0% |
| Total | $85.16 avg | 130,228 | $11.1M | 100% |
| Filing → |
| EGRX | SELL | 2016-11-14 | $4.2M | — | Filing → |
| EGRX | SELL | 2016-11-04 | $21.0M | — | Filing → |
| EGRX | SELL | 2016-09-30 | $10.9M | — | Filing → |